Corrigendum: A novel multiple-stage antimalarial agent that inhibits protein synthesis.

Baragaña, B; Hallyburton, I; Lee, MC; Norcross, NR; Grimaldi, R; Otto, TD; Proto, WR; Blagborough, AM; Meister, S; Wirjanata, G; +54 more... Ruecker, A; Upton, LM; Abraham, TS; Almeida, MJ; Pradhan, A; Porzelle, A; Martínez, MS; Bolscher, JM; Woodland, A; Luksch, T; Norval, S; Zuccotto, F; Thomas, J; Simeons, F; Stojanovski, L; Osuna-Cabello, M; Brock, PM; Churcher, TS; Sala, KA; Zakutansky, SE; Jiménez-Díaz, MB; Sanz, LM; Riley, J; Basak, R; Campbell, M; Avery, VM; Sauerwein, RW; Dechering, KJ; Noviyanti, R; Campo, B; Frearson, JA; Angulo-Barturen, I; Ferrer-Bazaga, S; Gamo, FJ; Wyatt, PG; Leroy, D; Siegl, P; Delves, MJ; Kyle, DE; Wittlin, S; Marfurt, J; Price, RN; Sinden, RE; Winzeler, EA; Charman, SA; Bebrevska, L; Gray, DW; Campbell, S; Fairlamb, AH; Willis, PA; Rayner, JC; Fidock, DA; Read, KD; Gilbert, IH; (2016) Corrigendum: A novel multiple-stage antimalarial agent that inhibits protein synthesis. Nature Research. DOI: https://doi.org/10.1038/nature18280

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1038/nature18280

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar